CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 718

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 13.58%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 60.03%
Services
Technology
Transportation
Utilities

27 INCREASED Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
NEUROCRINE BIOSCIENCES INC COM 39,050 5,858 17.65 1,000,000
CELGENE CORP COM 36,459 36,459 New 300,000
OVASCIENCE INC COM 33,996 10,504 44.71 747,000
ALKERMES PLC SHS 31,613 24,588 350 450,000
PORTOLA PHARMACEUTICALS INC COM 22,848 15,232 200 600,000
SORRENTO THERAPEUTICS INC COM NEW 22,610 9,690 75 1,750,000
REGULUS THERAPEUTICS INC COM 20,372 16,668 450 1,100,000
QUOTIENT LTD SHS 18,073 9,858 120 1,100,000
KITE PHARMA INC COM 16,687 10,143 155 255,000
ARDELYX INC COM 16,587 10,467 171.03 1,053,500
CHIMERIX INC COM 16,192 6,072 60 400,000
BRISTOL MYERS SQUIBB CO COM 15,230 6,092 66.67 250,000
OMEROS CORP COM 12,153 718 6.28 582,300
ADVAXIS INC COM NEW 7,556 4,406 139.86 839,500
COHERUS BIOSCIENCES INC COM 7,019 7,019 New 222,200
ALDER BIOPHARMACEUTICALS INC COM 6,720 2,688 66.67 250,000
APTOSE BIOSCIENCES INC COM NEW 5,384 5,384 New 1,083,333
DICERNA PHARMACEUTICALS INC COM 4,886 4,886 New 200,000
LIPOCINE INC NEW COM 4,827 4,827 New 666,666
AGENUS INC COM NEW 3,920 735 23.08 800,000